Nektar Therapeutics (NKTR) Receives $100M MOVANTIK-Related Milestone Payment (AZN)
Tweet Send to a Friend
Nektar Therapeutics (NASDAQ: NKTR) has received a $100 million payment under a license agreement with AstraZeneca (NYSE: AZN). The cash ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
